These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32843530)

  • 41. Comparative evaluation of SARS-CoV-2 IgG assays in India.
    Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
    J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic.
    Poljak M; Korva M; Knap Gašper N; Fujs Komloš K; Sagadin M; Uršič T; Avšič Županc T; Petrovec M
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests.
    Schnurra C; Reiners N; Biemann R; Kaiser T; Trawinski H; Jassoy C
    J Clin Virol; 2020 Aug; 129():104544. PubMed ID: 32663788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease.
    To KK; Chua GT; Kwok KL; Wong JS; Au DCY; Lam YY; Wong WH; Ho MH; Chan GC; Chui CS; Li X; Tung KT; Wong RS; Tso WW; Wong IC; Wong CS; Fong CH; Chan KH; Yuen KY; Ip P; Kwan MY
    Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115141. PubMed ID: 32795776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
    J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.
    Mitchell SL; St George K; Rhoads DD; Butler-Wu SM; Dharmarha V; McNult P; Miller MB
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
    Pickering S; Betancor G; Galão RP; Merrick B; Signell AW; Wilson HD; Kia Ik MT; Seow J; Graham C; Acors S; Kouphou N; Steel KJA; Hemmings O; Patel A; Nebbia G; Douthwaite S; O'Connell L; Luptak J; McCoy LE; Brouwer P; van Gils MJ; Sanders RW; Martinez Nunez R; Bisnauthsing K; O'Hara G; MacMahon E; Batra R; Malim MH; Neil SJD; Doores KJ; Edgeworth JD
    PLoS Pathog; 2020 Sep; 16(9):e1008817. PubMed ID: 32970782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
    Das MK; Chaudhary A; Bryan A; Wener MH; Fink SL; Morishima C
    Emerg Infect Dis; 2020 Oct; 26(10):2501-2503. PubMed ID: 32723430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications.
    Caini S; Bellerba F; Corso F; Díaz-Basabe A; Natoli G; Paget J; Facciotti F; De Angelis SP; Raimondi S; Palli D; Mazzarella L; Pelicci PG; Vineis P; Gandini S
    Euro Surveill; 2020 Jun; 25(23):. PubMed ID: 32553061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients.
    Wechselberger C; Süßner S; Doppler S; Bernhard D
    J Clin Virol; 2020 Oct; 131():104589. PubMed ID: 32810840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.
    Serrano MM; Rodríguez DN; Palop NT; Arenas RO; Córdoba MM; Mochón MDO; Cardona CG
    J Clin Virol; 2020 Aug; 129():104529. PubMed ID: 32659710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
    Erensoy S
    Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
    J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients.
    Walker SN; Chokkalingam N; Reuschel EL; Purwar M; Xu Z; Gary EN; Kim KY; Helble M; Schultheis K; Walters J; Ramos S; Muthumani K; Smith TRF; Broderick KE; Tebas P; Patel A; Weiner DB; Kulp DW
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32855181
    [No Abstract]   [Full Text] [Related]  

  • 59. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity.
    Perkmann T; Perkmann-Nagele N; Breyer MK; Breyer-Kohansal R; Burghuber OC; Hartl S; Aletaha D; Sieghart D; Quehenberger P; Marculescu R; Mucher P; Strassl R; Wagner OF; Binder CJ; Haslacher H
    Clin Chem; 2020 Nov; 66(11):1405-1413. PubMed ID: 32777031
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
    Hu F; Chen F; Ou Z; Fan Q; Tan X; Wang Y; Pan Y; Ke B; Li L; Guan Y; Mo X; Wang J; Wang J; Luo C; Wen X; Li M; Ren P; Ke C; Li J; Lei C; Tang X; Li F
    Cell Mol Immunol; 2020 Nov; 17(11):1119-1125. PubMed ID: 33037400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.